Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 202-216, February 2001

Treatment of acute ischemic stroke☆☆

  • Christopher Lewandowski, MD

      Affiliations

    • Department of Emergency Medicine, Henry Ford Hospital, Detroit, MI, and Case Western Reserve University, Cleveland, OH
  • ,
  • William Barsan, MD

      Affiliations

    • Department of Emergency Medicine, University of Michigan, Ann Arbor, MI.

Received 17 September 1999; received in revised form 2 August 2000; accepted 28 August 2000.

Abstract 

Acute ischemic stroke is the third leading cause of death in the United States and the leading cause of adult disability. The direct and indirect costs of stroke care exceed $51 billion annually. In 1996, the US Food and Drug Administration approved the first treatment for acute ischemic stroke, intravenous tissue plasminogen activator. Later that year, the National Institute of Neurologic Disorders and Stroke (a branch of the National Institutes of Health) convened a consensus conference on the Rapid Identification and Treatment of Acute Ischemic Stroke, setting goals for stroke care in the United States. Since then, it has become imperative that emergency physicians understand the pathophysiology of stroke, the basis and rationale for treatment, and the therapeutic approaches. This article reviews the state of the art of acute stroke treatment, its foundation, as well as its future. [Lewandowski C, Barsan W. Treatment of acute ischemic stroke. Ann Emerg Med. February 2001;37:202-216.]

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Editor’s Note: This article continues a series of special contributions addressing state-of-the-art techniques, topics, or concepts. State-of-the-art articles will be featured in Annals on a regular basis in the next several volumes.

☆☆ Address for reprints: Christopher Lewandowski, MD, Department of Emergency Medicine, Henry Ford Hospital, Detroit, MI 48202;,313-916-1553, fax 313-916-7437;,E-mail clewand1@hfhs.org .

PII: S0196-0644(01)09861-4

doi:10.1067/mem.2001.111573

Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 202-216, February 2001